PCSK9 inhibitor causes a reduction in the level of oxidatively modified low-density lipoproteines in patients with atherosclersosis
autor
vastutusandmed
Vadim Lankin, Alla Tikhaze, Irina Chazova, Margus Viigimaa
ilmumiskoht
[Tallinn]
kirjastus/väljaandja
ilmumisaasta
leheküljed
p. 38-39
seeria-sari
konverentsi nimetus, aeg
7th Baltic Atherosclerosis Society Congress, April 6-7, 2018
konverentsi toimumispaik
Tallinn, Estonia
ISSN
0235-8026
TTÜ struktuuriüksus
keel
inglise
Lankin, V., Tikhaze, A., Chazova, I., Viigimaa, M. PCSK9 inhibitor causes a reduction in the level of oxidatively modified low-density lipoproteines in patients with atherosclersosis // 7th Baltic Atherosclerosis Society Congress : [abstracts]. [Tallinn] : [Celsius Healthcare], 2018. p. 38-39. (Eesti Arst ; vol. 97, 2018 : lisa).